ShareValue scores for BHST: Valuation 43, Quality 23, Growth 71, Health 47.

BHST
NASDAQ

BioHarvest Sciences Inc. Common Stock

$2.51(+11.06%)
Loading chart...
Sentiment

Verdicts

Rating

Trap Risk

Return

6% to 18%
Valuation
43
Fair Value
Price vs Value
Quality
23
Weak
Business Strength
Growth
71
Strong
Revenue & Earnings
Health
47
Moderate
Financial Stability
Momentum
11
Bearish
Price Trend

Company Details

About

BioHarvest Sciences Inc. operates as a biotechnology company in Israel and the United States. It operates through two segments: Products and CDMO Services. The company develops botanical synthesis platform technology to produce plant cells with higher concentrations of active ingredients. It is involved in the research, development, manufacturing, marketing, and sale of science-based health and wellness nutraceutical solutions that are manufactured and sold as dietary supplements and functional food and beverages, as well as the manufacturing, marketing, and sale of science-based health, pharmaceutical, and cosmeceutical solutions. The company also provides contract development and manufacturing operation services. Further, it offers VINIA, a red grape cell dietary supplement containing the matrix of polyphenols contained in red wine. The company has a strategic collaboration with Tate & Lyle plc for the development of plant-based sweetener molecules. The company is based in Vancouver, Canada.

Score Analysis

AI Investment Thesis

Data as of:Aug 7, 2026
|
Last calculated:Aug 7, 2026